This review argues that a single cellular process — autophagy, the system cells use to digest and recycle their own damaged parts — may be the common thread linking almost every validated way to age better: caloric restriction, exercise, sleep, sauna and cold exposure, and drugs like rapamycin, metformin, spermidine and urolithin A. In simple animals (yeast, worms, flies, mice), switching off autophagy genes reliably abolishes the lifespan benefit of these interventions, which is strong causal evidence. In humans the story is only correlational, because we still lack a reliable, non-invasive way to actually measure autophagy in a living person. The authors frame this measurement gap as the central obstacle to turning decades of animal biology into real human anti-aging strategies.
For years, longevity science has looked like a grab-bag of unrelated hacks: eat less, move more, sleep well, take rapamycin, sit in a sauna. This review from the Buck Institute for Research on Aging makes the case that these interventions may not be unrelated at all. Underneath them, the authors argue, sits one conserved housekeeping process — autophagy — that cells use to break down worn-out proteins, damaged mitochondria and other molecular garbage and recycle the parts.
The Big Idea is causality, not just correlation. Across yeast, worms, flies and mice, researchers have repeatedly done the decisive experiment: take an intervention that extends life, then genetically disable the autophagy machinery. When they do, the benefit usually vanishes. Rapamycin stops working in flies missing Atg1 or Atg5. Spermidine stops working in animals missing Atg7 or Beclin1. Exercise stops extending worm lifespan when core autophagy genes are knocked down. Dietary restriction fails in autophagy-deficient yeast and worms. This repeated pattern — same result, many labs, many species, many interventions — is what elevates autophagy from “associated with aging” to “a hallmark of aging” that is at least partly causal.
The mechanistic spine is well mapped. Nutrient-sensing kinase mTOR suppresses autophagy when food is plentiful; starvation, exercise and rapamycin release that brake. AMPK, the cell’s low-energy sensor, pushes the other way and switches autophagy on. Sirtuins (fueled by NAD+) and the master transcription factor TFEB round out the control panel. Mitophagy — the selective recycling of broken mitochondria — appears especially relevant to muscle aging and is the specific target of urolithin A.
The honest part of the review is its ending. Nearly all the human evidence is indirect. We can measure static markers (LC3-II, p62) in a muscle biopsy or blood cell, but we cannot yet watch autophagic flux — the actual throughput of the recycling line — in a living human organ over time. Different tissues behave differently, blood cells vary enormously between people, and long-term studies linking autophagy to health outcomes barely exist. The authors are explicit: until we build reliable, non-invasive human flux assays and run longitudinal studies, autophagy-based interventions remain biologically plausible and animal-validated, but clinically unproven in people. The roadmap is clear; the human data are not yet on it.
Context / Source
- Open access paper: Links Between Autophagy and Healthy Aging, 15 March 2026.
- Authors / Institution / Country: Hiroshi Ebata & Malene Hansen, The Buck Institute for Research on Aging, Novato, California, USA.
- Journal: Journal of Molecular Biology, Vol. 438 (2026)
- Impact evaluation: JMB 2025 Journal Impact Factor = 4.5 (CiteScore = 10.2, JCR Q2). Using the JIF: “The impact score of this journal is 4.5, evaluated against a typical high-end range of 0–60+ for top general-science and biomedical journals, therefore this is a Medium impact journal.”